SS

Subrata Shome

Director Director DIN 06936430
DIN 06936430 First appointment Oct 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Subrata Shome

Data last updated:

Subrata Shome was a Director at Signova Biotech Private Limited (2015–2019) and Director at Simanika Life Sciences Private Limited (from 2014). The companies operate in Chemicals.

DIN 06936430
Primary Designation Director
Industry Chemicals
First Appointment 10 Oct 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Signova Biotech Private Limited U51397AS2015PTC012161
Director16 Jul 20152015Strike Off
Director10 Oct 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Simanika Life Sciences Private Limited
Signova Biotech Private Limited
Premium access

Shareholding and investment profile for Subrata Shome

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subrata Shome

Subrata Shome was first appointed on 10 Oct 2014 as Director at Simanika Life Sciences Private Limited. The most recent appointment on record is 16 Jul 2015 at Signova Biotech Private Limited.

Subrata Shome held 2 earlier board appointments: Signova Biotech Private Limited (Director, 16 Jul 2015 to 24 May 2019); Simanika Life Sciences Private Limited (Director, from 10 Oct 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available